Drug Database
Back to search

Belgium· BE-AMP-SAM485146-00

Obizur 500 U

A susoctocog alfa product containing susoctocog alfa, registered in Belgium by Baxalta Innovations. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedObizur 500 UATCB02BD14REGISTER NO.BE-AMP-SAM485146-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about susoctocog alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Susoctocog alfa is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD14 (susoctocog alfa), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search susoctocog alfa products by name

Susoctocog alfa · ATC B02BD14

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Susoctocog Alfa
Manufacturer
Baxalta Innovations
Country
Belgium (BE)
ATC code
B02BD14
ATC class
Susoctocog alfa
Defined daily dose
14 TSD, E
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    3667060
  • be_apb
    7721079

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Susoctocog alfa in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All susoctocog alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Obizur
  • Liechtenstein · Obizur
  • Norway · Obizur

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa9847b5-acb9-4f27-81bb-4653ff30c7fb
GET /v1/drugs/aa9847b5-acb9-4f27-81bb-4653ff30c7fb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Obizur 500 U",
  "name_fr": "Obizur 500 U",
  "name_nl": "Obizur 500 U",
  "amp_code": "SAM485146-00",
  "strengths": [
    "500.0000",
    "4.4000"
  ],
  "pack_count": 3,
  "substances": [
    "Susoctocog Alfa",
    "Sucrose",
    "Polysorbate 80",
    "Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Susoctocog Alfa",
  "authorisation_numbers": [
    "EU/1/15/1035/001",
    "EU/1/15/1035/003",
    "EU/1/15/1035/002"
  ]
}
API referenceMCP serverPlans

See everything about susoctocog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console